• As part of the agreement, Bionaturis Group will establish its first subsidiary company in China in the new technological area of Changshu (Jiangsu).
  • The new technological and industrial area of Changshu has been the one which has relied most on hosting the Spanish biotechnological group.
  • Bionaturis’ system for the development of biological medicinal products, known as Flylife, will serve as a baseline for the project.

Jerez de la Frontera, July 2nd 2015. Bionaturis Group and the Administrative Committee of Changshu New & Hi-Tech Industrial Development Zone –CNZ- (Jiangsu) – have signed a strategic agreement to host a subsidiary company of the biotechnological Spanish group, which will serve to develop and allocate biotechnological products in the Asian market.

As part of the agreement, within the park Bionaturis Group will have cutting-edge facilities in order to carry out its activities, as well as a diversity of direct incentive programs. In a first phase, facilities of 600 meters squared have been set out, which include a laboratory area and an administrative one. The laboratory area will host, among other services, Bionaturis’ biological medical production system, known as Flylife, and its capacity to develop state-of-the-art vaccines for human and animal health. In the new subsidiary company, the Spanish Group will also have a development department as well as a commercial office.

Currently, Bionaturis Group develops, at different stages, a variety of medicines intended for human health, as well as veterinary products that act or prevent habitual diseases in livestock (poultry, pigs, cattle…), farmed fish and pet animals.

Victor Infante, Chief Executive of Bionaturis Group, believes that “China is and will increasingly be one of the main markets in human and animal health. The commitment of Changshu’s authorities to host Bionaturis Group is a proof of the interest that the international community has on our products and services. We are convinced that we will repay their efforts. When developing our technical and commercial activity, we will encounter ideal conditions.”

China 1

About Bionaturis Group

Bionaturis Group offers the latest biotechnological products and services for human and animal health. Considered to be a world benchmark for vaccine development, Bionaturis ended the last financial year with a sales increase of 73% and a positive EBITDA of 29% compared to 2013. The biotechnological Group, which envisages a greater global access to health, is listed on the Spanish stock exchange for SMEs (ticker BNT).

About Changshu New & Hi-Tech Industrial Development Zone (CNZ)

CNZ is located in the center of the Yangtze River Delta region and is part of this Chinese coastal economic zone, particularly of the South-East Economic Development Zone of Changshu, the so-called Jiangsu, established in May 2003 by the local Provincial People’s Government. Among CNZ’s key advantages, the zone is located in a high traffic area, next to a high-tech industrial center. Since it was created 10 years ago, CNZ has achieved a high level of economic growth and technological innovation.

TO DOWNLOAD THE PRESS RELEASE, PLEASE CLICK HERE

 

www.bionaturis.com / info@bionaturis.com

http://www.china-csdz.com/eng/

 

For further information:                                                            

Bionaturis Press

Virginia Montero

+34 856 818 424 / 655 311047

info@bionaturis.com / press@bionaturis.com

 

Estudio de Comunicación: + 34 91 576 52 50